Anavex Life Sciences (AVXL) Confirms Information in July 27 Press Release Announcing Positive Results from Phase 2a Alzheimer's Trial for ANAVEX 2-73
Tweet Send to a Friend
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), confirms the information in the July 27, 2016 press release ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE